SIMPONI GOLIMUMAB 50MG INJECTION 0.5ML

Simponi (golimumab) is a monoclonal antibody used primarily for the treatment of autoimmune conditions. It is indicated for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Additionally, Simponi is used in the management of ulcerative colitis and Crohn’s disease.

The drug works by inhibiting tumor necrosis factor-alpha (TNF-alpha), a substance in the body that causes inflammation and is involved in the immune response. By blocking TNF-alpha, Simponi helps reduce inflammation, alleviate symptoms, and improve the quality of life for patients suffering from these chronic conditions.

Simponi is administered via subcutaneous injection, typically once a month after an initial loading dose. It is important for patients to be monitored for potential side effects, including increased risk of infections, as it suppresses the immune system.